Literature DB >> 11220983

Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea.

C A Pedone1, C C Arnaud, E R Postaire, C F Bouley, P Reinert.   

Abstract

The aim of this study was to determine if supplementation of healthy children with milk fermented by yogurt cultures and Lactobacillus casei strain DN-114 001 could affect the incidence of acute diarrhoea when compared with traditional yogurt. The study was a multicentre, randomised, double-blind trial, conducted over four months, on 928 children aged, at inclusion, 6-24 months. The study consisted of two periods: supplementation and observation. Subjects were supplemented daily with 100 g of one of the two dairy products being tested: standard yogurt and milk fermented by yogurt cultures and Lactobacillus casei (10(8) cfu/ml). Frequency or duration of any diarrhoea episode was evaluated. As far as frequency was concerned there was a statistically significant difference between the groups, the incidence of diarrhoea being significantly reduced by supplementation with L. casei fermented milk (15.9%) compared with yogurt (22%) (p = 0.03). These results suggest an additional benefit of L. casei in acute diarrhoea in children compared with standard yogurt.

Entities:  

Mesh:

Year:  2000        PMID: 11220983

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  31 in total

Review 1.  A gastroenterologist's guide to probiotics.

Authors:  Matthew A Ciorba
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

2.  Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk.

Authors:  Raish Oozeer; Antony Leplingard; Denis D G Mater; Agnès Mogenet; Rachel Michelin; Isabelle Seksek; Philippe Marteau; Joël Doré; Jean-Louis Bresson; Gérard Corthier
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

Review 3.  New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.

Authors:  Rachna Patel; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

4.  Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells.

Authors:  Isabelle Ingrassia; Antony Leplingard; Arlette Darfeuille-Michaud
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

5.  Differential activities of four Lactobacillus casei promoters during bacterial transit through the gastrointestinal tracts of human-microbiota-associated mice.

Authors:  R Oozeer; J P Furet; N Goupil-Feuillerat; J Anba; J Mengaud; G Corthier
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

6.  Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota.

Authors:  R Oozeer; D D G Mater; N Goupil-Feuillerat; G Corthier
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

7.  Caregivers' knowledge and use of fermented foods for infant and young children feeding in a rural community of odi, gauteng province, South Africa.

Authors:  Paul K Chelule; Mathildah M Mokgatle; Lindiwe I Zungu; Armelia Chaponda
Journal:  Health Promot Perspect       Date:  2014-07-12

8.  Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status.

Authors:  Néstor Pérez; Juan C Iannicelli; Cecilia Girard-Bosch; Silvia González; Ana Varea; Liliana Disalvo; María Apezteguia; Juan Pernas; Dimas Vicentin; Ricardo Cravero
Journal:  Eur J Nutr       Date:  2009-10-17       Impact factor: 5.614

9.  Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial.

Authors:  D Merenstein; M Murphy; A Fokar; R K Hernandez; H Park; H Nsouli; M E Sanders; B A Davis; V Niborski; F Tondu; N M Shara
Journal:  Eur J Clin Nutr       Date:  2010-05-19       Impact factor: 4.016

Review 10.  Probiotics and human health: a clinical perspective.

Authors:  H S Gill; F Guarner
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.